PUBPAT Advocacy on Policy
PUBPAT advocates for sound patent policy before the U. S. Patent and Trademark Office and many other policy makers.
Click Here to See PUBPAT in Congress
Comments to the U.S. Patent & Trademark Office
- European Commission
- Gowers Review of Intellectual Property
- National Institutes of Health (NIH)
Related News
- November 10, 2004: PUBPAT EXECUTIVE DIRECTOR DETAILS PROBLEMS WITH AND HARM CAUSED BY SOFTWARE PATENTS: Dan Ravicher Speaks in the European Parliament As Part of Foundation for a Free Information Infrastructure Conference
- May 24, 2004: PUBPAT EXECUTIVE DIRECTOR TESTIFIES BEFORE NIH REGARDING KEY AIDS DRUG PATENTS: PUBPAT Supports Request Asking Government to Allow the Production of Generic Drug
- February 23, 2004: PUBPAT PROVIDES COMMENTS TO USPTO ON INTER PARTES REEXAMINATION AND RULES GOVERNING PRACTITIONERS: Argues All Patents Should be Subject to Adversarial Post Grant Review and All Patent Attorneys Should Have Continuing Education Requirements